Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
genentech
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
4
×
san diego top stories
san francisco blog main
san francisco top stories
startups
4
×
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
ipo
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
agenus
bristol-myers squibb
cancer immunotherapy
celgene
clinical trials
drug prices
fda
What
bio
roundup
companies
drug
liver
pharmaceutical
aiming
alzheimer’s
ambys
appetite
approved
big
biotech
black
bread
butter
buyout
cancer
cash
control
deadly
deal
debuted
diabetes
diamond’s
different
digital
disease
diseases
drugs
eli
epidemic
fail
fatty
fda
formed
frenzied
future
gene
giant
Language
Current search:
genentech
×
startups
×
" san diego blog main "
×
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?